Scientific publications

Journal of Hepatology, 2025

AZD2693, a PNPLA3 antisense oligonucleotide, for the treatment of MASH in 148M homozygous participants: two randomized phase I trials

Armisen J., Rauschecker M., Sarv J. et al.

Cell Reports Medicine, 2025

Phase 1/2 trial of brogidirsen: Dual-targeting antisense oligonucleotides for exon 44 skipping in Duchenne muscular dystrophy

Komaki H., Takeshita E., Kunitake K. et al.

Scientific Reports, 2025

The BAMBOO method for correcting batch effects in high throughput proximity extension assays for proteomic studies

Smits H., Delemarre E., Pandit A. et al.

Scientific Reports, 2025

Associations of serum and tissue TIMP1 with host response and survival in colorectal cancer

Kehusmaa A., Tuomisto A., Sirniö P. et al.

British Journal of Dermatology, 2025

High-throughput proteomics identifies inflammatory proteins associated with disease severity and genetic ancestry in patients with hidradenitis suppurativa

Dimitrion P., Krevh R., Veenstra J. et al.

Journal of Infection, 2025

MicroRNA biomarkers and host response pathways in severe pulmonary hemorrhagic syndrome due to leptospirosis: A multi-omics study

Tran P., Limothai U., Dinhuzen J. et al.

American Heart Journal, 2025

Elevated lipoprotein(a) levels are independently associated with the presence of significant coronary stenosis in de-novo patients with stable chest pain

Brix G., Rasmussen L., Rohde P. et al.

Molecular Medicine, 2025

Differential expression of plasma proteins and pathway enrichments in pediatric diabetic ketoacidosis

Spagnolo P., Cela E., Patel M. et al.

Cancer Medicine, 2025

Assessing the Causal Effect of Circulating Protein‐To‐Protein Ratio on the Risk of Morbidity of Hepatocellular Carcinoma

Yue Q., Li X., Wan X. et al.

Chinese Journal of Cancer Research, 2025

Efficacy, safety, and multi-omics analysis of pembrolizumab combined with nab-paclitaxel and platinum as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: A single-arm phase 2 study

Gui L., Chen X., Zhang W. et al.

Frontiers in Oncology, 2025

Machine learning-based identification of proteomic markers in colorectal cancer using UK Biobank data

Radhakrishnan S., Nath D., Russ D. et al.

Brain Communications, 2025

Multi-omics characterization of improved cognitive functions in Parkinson’s disease patients after the combined metabolic activator treatment: a randomized, double-blinded, placebo-controlled phase II trial

Yulug B., Altay O., Li X. et al.

Cardiovascular Research, 2025

A novel approach to modelling acute cardiac decompensation in rats

Thiele A., Bartolomaeus H., Anandakumar H. et al.

Journal of Proteome Research, 2025

Olink Profiling of Intestinal Tissue Identifies Novel Biomarkers For Colorectal Cancer

Xiao C., Wu H., Long J. et al.

Journal of Proteomics, 2025

A comprehensive proteomic analysis reveals novel inflammatory biomarkers in intracranial aneurysms

Chen S., Hu Z., Zhao M. et al.

Neurology Neuroimmunology & Neuroinflammation, 2025

Aberrant Complement Activation Is Associated With Structural Brain Damage in Multiple Sclerosis

Oechtering J., Schaedelin S., Stein K. et al.

Diabetes Care, 2025

Large-Scale Plasma Proteomics Improves Prediction of Peripheral Artery Disease in Individuals With Type 2 Diabetes: A Prospective Cohort Study

Yu H., Zhang J., Qian F. et al.

Nature Human Behaviour, 2025

Plasma proteomic signatures of social isolation and loneliness associated with morbidity and mortality

Shen C., Zhang R., Yu J. et al.

Scientific Reports, 2025

Gut microbiota and blood biomarkers in IBD-Related arthritis: insights from mendelian randomization

Yang W., Cui M., Yang P. et al.

Scientific Reports, 2025

Serum inflammation-related proteins in a acute compartment syndrome rat model

Wang T., Cao J., Hou Z. et al.